Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor Prasugrel Transition Study
NCT01852019Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Jun 2013
- Primary completion
- Jul 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of cangrelor in coronary artery disease (CAD), sponsored by The Medicines Company. Started Jun 2013; status: completed.
02
Drugs
cangrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01852019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01852019.